1. Home
  2. GROW vs CTSO Comparison

GROW vs CTSO Comparison

Compare GROW & CTSO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo U.S. Global Investors Inc.

GROW

U.S. Global Investors Inc.

N/A

Current Price

$2.97

Market Cap

32.7M

Sector

Finance

ML Signal

N/A

Logo Cytosorbents Corporation

CTSO

Cytosorbents Corporation

HOLD

Current Price

$0.38

Market Cap

29.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GROW
CTSO
Founded
1968
1997
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Managers
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
32.7M
29.3M
IPO Year
1995
2008

Fundamental Metrics

Financial Performance
Metric
GROW
CTSO
Price
$2.97
$0.38
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
$5.38
AVG Volume (30 Days)
30.5K
248.3K
Earning Date
05-11-2026
05-01-2026
Dividend Yield
3.53%
N/A
EPS Growth
N/A
65.79
EPS
0.27
N/A
Revenue
$23,850,609.00
$22,503,908.00
Revenue This Year
N/A
$10.34
Revenue Next Year
N/A
$22.41
P/E Ratio
$11.07
N/A
Revenue Growth
N/A
48.53
52 Week Low
$2.23
$0.35
52 Week High
$3.65
$1.22

Technical Indicators

Market Signals
Indicator
GROW
CTSO
Relative Strength Index (RSI) 52.11 41.13
Support Level $2.88 $0.36
Resistance Level $3.26 $0.73
Average True Range (ATR) 0.10 0.05
MACD -0.03 0.00
Stochastic Oscillator 26.97 15.34

Price Performance

Historical Comparison
GROW
CTSO

About GROW U.S. Global Investors Inc.

US Global Investors Inc is a registered investment advisory firm. The company manages the following business segments: Investment management services; through which the company offers, to U.S. Global Investors Funds (USGIF or the Funds) and exchange-traded fund (ETF) clients, a range of investment management products and services to meet the needs of individual and institutional investors; and Corporate Investments, through which the company invests for its own account in an effort to add growth and value to its cash position. It derives all its revenue from Investment management services.

About CTSO Cytosorbents Corporation

CytoSorbents Corp is a leader in blood purification for the treatment of life-threatening conditions in the intensive care unit and cardiac surgery. CytoSorbent's proprietary blood purification technologies are based on biocompatible, high-porous polymer beads that can actively remove toxic substances from blood and other bodily fluids by pore capture and surface adsorption. CytoSorbent's technologies are used in several broad applications. Specifically, two important applications are: the removal of blood thinners during and after cardiothoracic surgery to reduce the risk of severe bleeding, and the removal of inflammatory agents and toxins in common critical illnesses that can cause massive inflammation, organ failure, and patient death. Geographically, in the USA, Germany, and Others.

Share on Social Networks: